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Sirt3Sirt3, a mitochondrial NAD+-dependent deacetylase, is regarded as a potential regulator in cellular metabo-
lism. However, the role of Sirt3 in the regulation of mitochondrial FoF1ATPase and the linkage to mitochon-
drial diseases is unclear. In this study, we demonstrated a role of Sirt3 in the regulation of FoF1ATPase
activity in human cells. Knockdown of Sirt3 in 143B cells by shRNA transfection caused increased acetylation
levels of the α and OSCP subunits of FoF1ATPase. We showed that Sirt3 physically interacted with the OSCP
and led to its subsequent deacetylation. By incubation of mitochondria with the puriﬁed Sirt3 protein, Sirt3
could regulate FoF1ATPase activity through its deacetylase activity. Moreover, suppression of Sirt3 reduced
the FoF1ATPase activity, consequently decreased the intracellular ATP level, diminished the capacity of mito-
chondrial respiration, and compromised metabolic adaptability of 143B cells to the use of galactose as the en-
ergy source. In human cells harboring ≅85% of mtDNA with 4977 bp deletion, we showed that oxidative
stress induced a reduction of Sirt3 expression, and an increased acetylation of the OSCP subunit of FoF1-
ATPase. Importantly, the expression of Sirt3 was also decreased in the skin ﬁbroblasts from patients with
CPEO syndrome. We further demonstrated that oxidative stress induced by 5–10 μM of menadione impaired
the Sirt3-mediated deacetylation and activation on FoF1ATPase activity through decreasing the protein level
of Sirt3. Our ﬁndings suggest that increased intracellular ROS levels might modulate the expression of Sirt3
which deacetylates and activates FoF1ATPase in human cells with mitochondrial dysfunction caused by a
pathogenic mtDNA mutation.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Acetylation of proteins on lysine residues is a dynamic posttransla-
tional modiﬁcation that is known to play a key role in the regulation of
diverse biological functions [1,2]. In addition to its important roles in biol-
ogy, lysine acetylation of proteins controlled by acetyltransferases and
deacetylases are intimately linked to aging and several human diseases
such as cancer, neurodegenerative disorders, and cardiovascular diseases
[3–6]. Increasing evidence reveals that protein acetylation can be mod-
ulated in mammalian cells as a response to oxidative stress and DNA
damage [7–9]. Since a proteomic screening identiﬁed a widespread
acetylation of mitochondrial proteins [10], there has been increasing
evidence to support the notion that reversible lysine acetylation plays
an important role in the regulation of mitochondrial function, which
maybe altered in response to environmental factors and dietary interven-
tions, respectively. However, the biological consequences of alterations inandMolecular Biology, National
ei 112, Taiwan. Tel.: +886 2
c.edu.tw (Y.-H. Wei).
rights reserved.the acetylation of mitochondrial proteins and the linkage to human dis-
eases have remained poorly understood.
Sirtuins are a conserved family ofmammalian proteins that control a
variety of cellular function via its NAD+-dependent deacetylase activity.
There is increasing evidence to reveal that sirtuins play a critical role in
the regulation of metabolism and the aging process through distinct
pathways [11,12]. Sirt3 is the best characterized sirtuin in mitochon-
dria and has emerged as the major regulator of mitochondrial protein
deacetylation [13]. Abundant evidence supports the pivotal role of
Sirt3 in the regulation ofmitochondrialmetabolism and energy homeo-
stasis, depending on the relevance of its mitochondrial targets in meta-
bolic pathways. It was reported that Sirt3 expression was altered in
mice as a response to calorie restriction and other dietary interventions
[14–16]. Recent studies of fasting mice revealed that Sirt3 was up-
regulated and resulted in the activation of TCA cycle, β-oxidation and
ketogenesis [17–19]. Importantly, in contrast to calorie restriction, a de-
cline in Sirt3 expressionwas observed in oldmice, inmicewith diabetes
or in those fed on high-fat diets [14,20–22]. These ﬁndings suggest that
down-regulation of Sirt3 in affected tissues may be associated with the
onset or progression of some metabolic diseases.
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of ATP synthesis on FoF1ATPase with the transmembrane proton gradi-
ent established by electron transport in the respiratory chain. The FoF1-
ATPase in human cells is composed of 15 subunit proteins and consists
of two structural domains, F1 and Fo, which are the catalytic core and
the membranous proton channel, respectively [23]. These two domains
are held together by a central stalk and a peripheral stalk. Tight regula-
tion of the mitochondrial FoF1ATPase in response to cellular energy
need has been demonstrated in several animals and in different types
of tissues, like heart muscle, skeletal muscle and brain [24]. In addition
to controlling the amount of FoF1ATPase, direct regulation of FoF1ATPase
activity is frequently used to meet the change of energy demand in
tissues or organs in response to physiological or pathological stimuli
[24–27]. Abnormalities in the function or regulation of FoF1ATPase activ-
ity were related to human diseases including neurodegenerative disor-
ders, diabetes and cardiac hypertrophy [20,28–31]. Lysine acetylation
of FoF1ATPase in mouse liver mitochondria was identiﬁed in a previous
proteomic study [10], but the relationship between the acetylation sta-
tus and the biochemical function of FoF1ATPase has not been elucidated.
In this study, we identiﬁed acetylated lysine residues in several
subunits of FoF1ATPase and showed that the OSCP (oligomycin sensi-
tivity conferring protein) subunit of the enzyme is a new target of
Sirt3 in human cells. Endogenous Sirt3 could interact with OSCP to
regulate the FoF1ATPase activity through deacetylation. Importantly,
we found that FoF1ATPase acetylation and Sirt3 expression are altered
in human cells harboring the 4977 bp deletion of mtDNA. We further
demonstrated that mitochondrial dysfunction-elicited oxidative
stress can affect the expression and function of Sirt3 in mitochondria
of human cells.
2. Materials and methods
2.1. Cell lines and culture conditions
The 143B human osteosarcoma cells were purchased from American
Type Culture Collection (ATCC, Manassas, VA, USA). The cybrids harbor-
ing thewild-type (0%) and about 85% 4977 bp-deletedmtDNA (85%CD),
respectively, were made by fusing mtDNA-less 143B osteosarcoma (ρ0)
cells with enucleated skin ﬁbroblasts from a patient with clinically prov-
en CPEO syndrome according to amethod developed previously [32–34].
The proportions of 4977 bp-deleted mtDNA in the cybrids used in this
studywere determined by Southern hybridization established in our lab-
oratory [32]. The cybrids and 143B cells were grown in DMEM (Gibco,
Invitrogen Corp., Carlsbad, CA) supplemented with 5% FBS, 100 μg/ml
pyruvate, 50 μg/ml uridine and antibiotics composed of 100 U/ml penicil-
lin G and 100 μg/ml streptomycin sulfate (Biological Industries, Kibbutz
Beit Haemek, Israel) at 37 °C in a chamber of humidiﬁed 5% CO2/95%
air. The primary cultures of skin ﬁbroblasts were established from 2 pa-
tients with CPEO (chronic progressive external ophthalmoplegia) syn-
drome and 2 healthy normal subjects, respectively, as described in the
previous study [33,34]. The proportions ofmtDNAwith the 4977 bp dele-
tion in skinﬁbroblasts from the2CPEOpatientswere about 6.5% and4.5%,
respectively [34]. All the experiments were performed on skin ﬁbroblasts
at passages 5 to 8, which were cultured in the DMEM containing 5% FBS
and antibiotics for 4 days.
2.2. Chemicals and antibodies
Nicotinamide, menadione, N-acetylcysteine (NAC), oligomycin A and
L-galactose were purchased from Sigma-Aldrich Chemical Co. (St. Louis,
MO, USA). Antibodies against acetyllysine, Sirt3 and Sirt1 were pur-
chased from Cell Signaling Technology (Beverly, MA); the antibodies
against the protein subunits of mitochondrial FoF1ATPase (α, β, γ and
OSCP subunits) were purchased from Molecular Probes (Eugene, OR);
an Hsp60 antibody was supplied by Millipore (Billerica, MA); VDAC-1
and Sirt5 antibodies was from Abcam (Cambridge, UK); the α-tubulinantibody was supplied by Sigma-Aldrich (St. Louis, MO, USA). The anti-
bodies against acetyllysine, Sirt3, Sirt1 and FoF1ATPase γ subunit were
diluted by 1:1000 for Western blotting. Dilutions of other antibodies
used for Western blot were 1:5000.
2.3. Stable cell line with knockdown of Sirt3
Sirt3was knocked downbyusing a short-hairpin RNA (shRNA)plas-
mid purchased from the RNAi Core Facility at Academia Sinica, Taipei,
Taiwan. The shSirt3 and shLuci (luciferase control gene) constructs
were made by using the pLKO.1 plasmid and the target sequences
were 5′-GTGGGTGCTTCAAGTGTTGTT-3′ and 5′-CAAATCACAGAATCG
TCGTAT-3′, respectively. The 143B cells were transfected with 4 μg/well
shRNA plasmid using the lipofectamine/PLUS reagent (Invitrogen)
according to the protocol recommended by the manufacturer. After
transfection for 24 h, we selected stable cells using 1 μg/ml puromy-
cin (Invitrogen). After 3 days of selection, the remaining cells were
trypsinized and cultured in a selective medium in 96-well culture
plates by serial dilution to obtain single colonies. After colonies had
been formed, single colonies were picked and transferred into a
new set of 12-well culture plates. The expression level of the Sirt3
protein in each clone was examined 6 weeks after transfection.
2.4. Over-expression of OSCP
A full-length cDNA encoding human OSCP was obtained by re-
verse transcription-PCR. To create an OSCP mammalian expression
vector (pEGFP-N2-OSCP), the OSCP cDNA was cloned into the EcoRI
and ApaI sites of the pEGFP-N2 vector (Clontech, Terra Bella, CA,
USA). The pEGFP-N2-OSCP plasmid was ampliﬁed and transfected
into the HEK293T cells by using TurboFect™ in vitro transfection
reagent (Fermentas Life Science, Vilnius, Lithuania) according to
the protocol recommended by the manufacturer. HEK293T cells
transfected with the pEGFP-N2 vector were used as a control.
2.5. Isolation of mitochondria
Mitochondria were isolated from cultured cells by incubating cell
pellets in the SEH buffer (250 mM sucrose, 1 mM EGTA, 3 mM HEPES,
pH 7.2) containing complete EDTA-free protease inhibitors (Roche).
Cells were homogenized on ice by 6–8 strokes in a Dounce tissue ho-
mogenizer (Bellco Glass Inc., Vineland, NJ) with a pestle of small clear-
ance. Cell homogenate was centrifuged 2 times at 800 ×g for 10 min at
4 °C to remove the debris, and themitochondria were collected by cen-
trifugation at 12,000 ×g for 15 min. The pellet was subsequently
washed with the isolation buffer. After another round of centrifugation
at 12,000 ×g, the pellet was collected as the enriched mitochondrial
fraction. Mitochondrial proteins were then extracted by a lysis buffer
containing 1% lauryl-maltoside (Sigma-Aldrich) in the PBS buffer.
2.6. Immunoprecipitation and acetylation assays
FoF1ATPase was puriﬁed from isolated mitochondria by using the
immunocapture beads (Mitoscience) according to the manufacturer's
recommendation. In general, we isolated the respiratory enzyme com-
plex from 1 to 2 mg of mitochondria of 143B cells by using 10 μl
immunocapture beads. For measurement of the expression of Sirt3 by
Western blotting, we used 50 μg of proteins from the cell lysate and
probedwith the rabbit polyclonal antibody as described above. To exam-
ine the acetylation status of FoF1ATPase, 1 mg of mitochondrial lysate
from 143B cells was immunoprecipitated overnight with 5 μl of a poly-
clonal acetyllysine antibody. All the immunoprecipitated proteins with
lysine acetylation were washed four times in the lysis buffer, and then
separated by SDS-PAGE and subjected toWestern blotting for the assess-
ment of the acetylation levels of the subunits of FoF1ATPase. For Sirt3 and
OSCP immunoprecipitation, 0.5 mg of total proteins (or mitochondrial
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body or 2 μl of anti-EGFP antibody. At least four separated immunopre-
cipitations followed by Western blotting were performed.
2.7. Western blot analysis
An aliquot of 30 μg proteinswas separated on a 10% SDS-PAGEgel and
blotted onto a piece of the PVDF membrane (Amersham Biosciences).
Nonspeciﬁc binding was blocked by incubating with 3% skim milk in
TBST buffer (50 mM Tris–HCl, 150 mM NaCl, 0.1% Tween 20, pH 7.4)
and the membrane was blotted with indicated primary antibodies. After
incubation with an HRP-conjugated secondary antibody the protein
band was visualized by an ECL chemiluminescence reagent according to
the manufacturer's instructions (Perkin-Elmer Life Sciences Inc., Boston,
MA). The chemiluminescent signal was detected and recorded by the
X-ray ﬁlm exposure. The intensity of each protein band was quantitated
by Image Scanner III LabScan 6.0 (GE Healthcare BioSciences Corp.,
Piscataway, NJ). Analysis of Western blots was performed with three in-
dependent experiments and representative blots are presented.
2.8. Measurement of oxygen consumption rate
Oxygen consumption rate was measured on a set of 782 Oxygen
Meter (Strathkelvin Instruments, Scotland, UK) with a water circulation
system maintained at 37 °C. About 5×105 cells were suspended in
330 μl assay buffer (125 mM sucrose, 65 mM KCl, 2 mM MgCl2,
20 mM phosphate buffer, pH 7.2) and the oxygen consumption rate
wasmeasured after transferring cell suspension to the incubation cham-
ber. In order to determine the respiratory function of mitochondria, we
measured the succinate-supported respiration rate and the respiratory
control ratio (RCR) of cells. Approximately 0.0003% digitonin (Sigma-
Aldrich Chemical Co., St. Louis, MO) was used to permeabilize the plas-
ma membrane. After addition of 10 mM succinate to the reaction
chamber as the electron donor, we recorded the succinate-supported
respiration rate for 5 min and then injected 3 μl of 100 mM ADP to at-
tain a ﬁnal ADP concentration of 1 mM in the assay medium. The rate
of activated (State 3) respiration was recorded for the calculation of RCR
of the mitochondria. After recording the oxygen consumption rate of
the mitochondrial preparation, KCN was added to a ﬁnal concentration
of 0.1 mM to block mitochondrial respiration for the calculation of
non-mitochondrial oxygen consumption rate.
2.9. Measurement of intracellular ATP content
Intracellular ATP level wasmeasured by the Bioluminescent Somatic
Cell Assay Kit (Sigma-Aldrich) according to the manufacturer's instruc-
tions. An aliquot of 50 μl suspension of viable cells was mixed with
150 μl of Somatic Cell Releasing Reagent to release the intracellular
ATP. Half of the mixture was then transferred into a black 96-well
plate (OptiPlate™, Packard Biosciences, Groningen, The Netherlands)
containing 100 μl of ATP assay mix and the luminescence intensity
was measured by a Victor2™ 1420 Multilabel Counter (Perkin-Elmer
Life Sciences, Inc., Boston, MA). The luminescence intensity was then
divided by the cell number to calculate the ATP content per cell.
2.10. Determination of intracellular ROS
For the measurement of O2•− level, cells were incubated in a medium
containing 5 μg/ml hydroethidine (HE, Molecular Probes) at 37 °C in
the dark for 30 min. After trypsinization, cells were resuspended in
50 mM HEPES buffer (pH 7.4) and subjected to analysis on a Beckman-
Coulter ﬂow cytometer (Model EPICS XL-MCL, Miami, FL). The excitation
wavelength was set at 488 nm and the ﬂuorescence intensity of emitted
ﬂuorescence of a total of 10,000 cells at 580 nmwas recorded on channel
FL2. Data were acquired and analyzed using the EXPO32™ software
(Beckman-Coulter, Miami, FL).2.11. Assay of the ATPase activity
The FoF1ATPase activity was measured for the fractions enriched
withmitochondrial membranes, which were obtained from the disrup-
tion of mitochondria by 3 cycles of freezing in liquid nitrogen and
thawing at 37 °C. Submitochondrial particles were brought down by
centrifugation at 16,000 ×g 25–30 min more complete pelleting at
4 °C and were washed with the SEH buffer. The supernatant was
centrifuged again and the resulting pellet was suspended in the SEH
buffer. Mitochondrial suspension was added to a reaction mixture and
the decrease in the absorbance at 340 nm was measured for 10 min
at 30 °C. The ATP hydrolysis activity of FoF1ATPase was measured by
coupling the production of ADP to the oxidation of NADH via reactions
catalyzed by pyruvate kinase and lactate dehydrogenase [36]. The reac-
tion mixture in a ﬁnal volume of 1 ml contained 50 mM HEPES
(pH 7.2), 2 mM ATP, 3 mMMgCl2, 50 mM KCl, 0.2 mM EDTA, 0.5 mM
NADH, 100 μM rotenone, 2 mM phosphoenol pyruvate, 10 units of
pyruvate kinase, and 10 units of lactate dehydrogenase. An extinction
coefﬁcient of 6.22 mM−1 cm−1 of NADH was used in calculating the
enzyme activity in micromole ATP hydrolyzed per minute. The ATP
hydrolysis activity of FoF1ATPase of the mitochondrial proteins was
about 0.1–0.2 μmol ATP hydrolyzed min−1 mg−1 protein.
2.12. Assay of in vitro deacetylation
To assess the in vitro effects of Sirt3-mediated deacetylation on
FoF1ATPase, we disrupted mitochondrial suspension containing 1%
lauryl maltoside by three cycles of freezing in liquid nitrogen and
thawing at 37 °C. A mitochondrial suspension (200 μg of protein) was
then incubated in a deacetylase reaction buffer (150 mM NaCl, 1 mM
MgCl2, 10 mM NAD+, 50 mM Tris–HCl, pH 8.0) containing 900 ng of
puriﬁed Sirt3 (Calbiochem Inc.) in a total reaction volume of 250 μl.
After incubation of mitochondria with Sirt3 proteins for 1.5 h at 37 °C,
the reaction mixture was placed on ice for the subsequent assay of the
FoF1ATPase activity. The reaction mixture without the addition of Sirt3
proteins was used as the control.
2.13. Propidium iodide staining
Propidium iodide (PI) staining was used to assess cell death. Cells
collected by trypsinization and centrifugation were washed with cold
PBS and prepared as a single cell suspension by mechanical blowing
with PBS, and ﬁxed with 70% ethanol at 4 °C for 20 min. Fixed cells
were washed with PBS and stained with PI (4 μg/ml in PBS containing
1% Triton X-100, 0.1 mg/ml RNase A) for 30 min at 4 °C in the dark.
The DNA content in PI-stained cells was detected by ﬂow cytometry.
2.14. Statistical analysis
Data processing and statistical analysis were performed by using the
Microsoft Excel statistical package and the SPSS version 8.0 (SPSS Inc.,
Chicago, IL). The data are presented asmean±SD of the results obtained
from three independent experiments. The signiﬁcance level was deter-
mined by Student's t test of data between two groups and for more
than two groups datawould be compared by ANOVA/post hoc test. A dif-
ference is considered to be statistically signiﬁcant when Pb0.05.
3. Results
3.1. Sirt3 regulates the acetylation of mitochondrial FoF1ATPase in human
cells
In the prediction research according to the UniProt database, we
searched most of the human FoF1ATPase protein subunits containing
putative acetylated lysine residues (Supplementary Table). Multiple
acetylated residues of these proteins have been identiﬁed in human
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a sirtuin is involved in the regulation of FoF1ATPase acetylation, 143B
cells treated with nicotinamide (NAM), a broad-spectrum sirtuin inhibi-
tor, were subjected to immunoprecipitation of the FoF1ATPase complex
for subsequent detection of acetylation by Western blot using an anti-
body that recognized internal acetyllysine residues. The efﬁciency of
NAM inhibition on sirtuin deacetylase was certiﬁed dependent on in-
creased acetylation level of acetyl-CoA synthetase upon NAM treatment
(Supplementary Fig. 1). As shown in Fig. 1A, inhibition of sirtuin activity
resulted in enhanced FoF1ATPase acetylation in NAM-treated cells as
compared with the control. To further identify potential deacetylation
targets of sirtuin on the FoF1ATPase, we used anti-acetyllysine antibody
to immunoprecipitate the acetylated proteins from the mitochondria
of 143B cells with or without NAM treatment. These proteins were
immunoblotted with antibodies against different protein subunits of
FoF1ATPase to assess the acetylation levels. Western blotting conﬁrmed
acetylation of multiple FoF1ATPase subunits, which were identiﬁed in
previous experiments. Among these acetylated protein subunits, onlyHSP60
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Fig. 1. Sirt3 regulates the acetylation levels of mitochondrial FoF1ATPase. (A) FoF1ATPase wa
protein acetylation was determined by Western blotting with antibody against acetyll
immunocapture. (B) Equal amounts of mitochondrial lysates from the control or nicotinam
body and then subjected to immunoblotting with monoclonal antibodies against several FoF
and Hsp60 were used as the loading controls in the input. (C) Knockdown of Sirt3 in 143B
mitochondrial Sirt3 in cells transfected with control shRNA (luciferase) or Sirt3 shRNA were
of FoF1ATPase in Sirt3-knockdown cells. Equal amounts of mitochondrial proteins from the
against FoF1ATPase (D) and acetyllysine (E), respectively. Immunoprecipitates were inversel
to assess the degree of acetylation of FoF1ATPase. All analyses were performed with three indethe OSCP subunit of FoF1ATPase exhibited increased acetylation level in
cells with NAM inhibition of the sirtuin activity (Fig. 1B). To investigate
the potential role of Sirt3 in regulating deacetylation of FoF1ATPase,
143B cells were transfected with shRNAs targeting at endogenous Sirt3
or luciferase (as the control). Stable expression of Sirt3 shRNA in cells
almost entirely repressed the expression of endogenous Sirt3 at the pro-
tein level (Fig. 1C). To assess whether FoF1ATPase acetylation could be
regulated by Sirt3, we immunopuriﬁed FoF1ATPase from the control
and Sirt3 knockdown cells and subjected to acetylation analysis. As indi-
cated in Fig. 1D, Sirt3 knockdown cells showed increased acetylation
level of FoF1ATPase. Two proteins of about 56 kDa and between 17 and
55 kDa in immunoprecipitated FoF1ATPase showed obvious alteration
in the acetylation levels. The molecular weights of these two protein
bands nicely matched the polypeptides of FoF1ATPase, α and OSCP.
After immunoprecipitation with acetylated mitochondrial proteins we
demonstrated that suppression of Sirt3 resulted in a signiﬁcant increase
in the acetylation levels ofα and OSCP subunits (Fig. 1E), withmolecular
mass of 56 kDa and 23 kDa, respectively. In particular, the OSCP subunitIP: FoF1ATPase 
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pendent experiments and representative blots are presented.
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with the control cells. These results reveal that the α and OSCP subunits
of FoF1ATPase are targets of deacetylation by Sirt3 deacetylase.
3.2. Physical association of Sirt3 with the OSCP subunit of FoF1ATPase
To test whether Sirt3 physically interacts with FoF1ATPase, we
immunoprecipitated Sirt3 from the mitochondrial lysate of 143B cells
and subjected these immunoprecipitated components to probe for
associated proteins using multiple antibodies against different protein
subunits of FoF1ATPase. As shown in Fig. 2A, Sirt3 apparently interacted
with the OSCP subunit, but not with other FoF1ATPase subunits. This re-
sult revealed that Sirt3 could regulate the acetylation level of OSCP
through protein binding and deacetylation. To further conﬁrm the asso-
ciation between OSCP and Sirt3, we transfected HEK293T cells with an
expression vector of OSCP. HEK293T cells were transiently transfected
with EGFP-OSCP and EGFP vector, respectively. Moreover, proteins
obtained from these cells were used to immunoprecipitate EGFP-OSCP
and subjected to Western blot analysis for associated Sirt3. As shown
in Fig. 2B, an interaction was found to exist between exogenously
expressed OSCP and endogenous Sirt3. Additionally, when the OSCP-
overexpressing cells were co-transfected with a shRNA of Sirt3, OSCP
displayed increased acetylation (Fig. 2C). These results support theC
EGFP-OSC
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Fig. 2. Sirt3 physically interacts with the OSCP subunit of FoF1ATPase. (A) Endogenous Sirt3 a
Sirt3 and then subjected to Western blot analysis with an antibody against OSCP. (B) Intera
with EGFP-OSCP or EGFP vector. EGFP-OSCP was immunoprecipitated from cell lysates by u
antibodies, respectively, to examine Sirt3-OSCP association (left panel). Right panel present
tibodies, respectively. (C) Knockdown of Sirt3 increases the acetylation level of exogenous
with a vector expressing EGFP-OSCP. Exogenous OSCP was immunoprecipitated and the acet
yses were carried out in three independent experiments and representative blots are presenotion that the OSCP subunit of FoF1ATPase is preferentially subjected
to Sirt3-mediated deacetylation through the interaction with Sirt3.
3.3. Regulation of FoF1ATPase activity through the deacetylase activity of
Sirt3
To investigate the biochemical consequence of FoF1ATPase acetyla-
tion, we ﬁrst examined the effect of increased FoF1ATPase acetylation
on its enzyme activity. We isolated mitochondria from 143B cells with
stable expression of shRNA speciﬁcally targeting to Sirt3 or luciferase
to determine whether a deﬁciency of Sirt3 affects the enzyme activity
of FoF1ATPase. As shown in Fig. 3A, knockdown of Sirt3 resulted in a
signiﬁcant decrease in the ATP hydrolysis activity of FoF1ATPase in
143B cells (33% reduction in the activity compared to luciferase con-
trol). A similar reduction in FoF1ATPase activity was also observed in
143B cells after treatment with NAM (Supplementary Fig. 2A). These
results indicate that the acetylation status of the polypeptides of
FoF1ATPase is correlated with its enzymatic activity. To further explore
whether Sirt3 could directly affect the FoF1ATPase activity, we isolated
the mitochondria of 143B cells and incubated them with the recombi-
nant Sirt3 protein. In this experiment, we incubated the freeze–thawed
suspensions of mitochondria, often used to determine the enzyme
activities of electron transport chain (ETC), with recombinant Sirt3 inP
6
CP
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ction between exogenously expressed OSCP and Sirt3. HEK293T cells were transfected
sing an EGFP-antibody and subsequently immunoblotted with anti-Sirt3 and anti-OSCP
s the result of immunoblot analysis of the lysate with anti-OSCP and anti-α-tubulin an-
OSCP. shRNA targeting Sirt3 or luciferase control was cotransfected into HEK293T cells
ylation level was determined byWestern blot with an anti-acetyllysine antibody. Anal-
nted.
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measured the ATP hydrolysis activity of FoF1ATPase. As revealed
in Fig. 3B, incubation with exogenous Sirt3 dramatically enhanced
FoF1ATPase activity in a NAD+-dependent manner and the increased
activity was abolished by the addition of NAM. These observations indi-
cate that the positive effect of Sirt3 on FoF1ATPase activity was due to its
deacetylase activity.We next askedwhether alteration in the FoF1ATPase
activity might affect the intracellular ATP level when Sirt3 is deﬁcient.
Consistent with the reduction of FoF1ATPase activity, a decrease of
approximately 25% in the intracellular level of ATP was observed in the
Sirt3 knockdown cells (Fig. 3C). A similar reduction in the ATP level
was observed in cells treated with NAM as compared with control
(Supplementary Fig. 2B). In the Supplementary Fig. 3, we also deter-
mined the lactate production rate of cells to eliminate the possibility
that decreased ATP levels in Sirt3-deﬁcient cells was caused by an ef-
fect on the glycolytic pathway. Besides, we showed that suppression
of the Sirt3 expression rendered FoF1ATPase more sensitive toshLuci shSirt3
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Fig. 3. Sirt3 affects the enzyme activity of FoF1ATPase through deacetylation. (A) Sirt3 knock
tochondrial particles (SMP) obtained from 143B cells expressing control or Sirt3 shRNA we
the presence of an ATP regenerating system, see Materials and methods, was measured spec
NADH. ATP hydrolysis activity of FoF1ATPase was normalized by maltoside-solubilized mi
inhibits the FoF1ATPase activity in vitro. Solubilized mitochondria obtained from 143B ce
buffer containing recombinant Sirt3 in the presence or absence of NAD+ and NAM. After in
activity of FoF1ATPase. Values are expressed as the mean±SD of the results from three indep
(C) Intracellular levels of ATP were determined in 143B cells with Sirt3-deﬁciency by kno
(D) Normalized levels of ATP in control and Sirt3 knockdown cells with or without oligomyoligomycin A (Fig. 3D). The intracellular ATP content in the Sirt3
knockdown cells was lower than those of control cells after treat-
ment with oligomycin A. These results suggest that knockdown of
Sirt3 led to an elevation of the acetylation level of FoF1ATPase and
decrease of its enzyme activity, and culminated in an energetic deﬁ-
ciency and rendered mitochondria more sensitive to oligomycin A.
3.4. Sirt3 deﬁciency leads to the impairment of mitochondrial respiration
and compromised adaptability to galactose-induced stress
To explore possible biochemical consequences of the alteration in
the acetylation of FoF1ATPase, we evaluated whether suppression of
Sirt3 could affect the respiratory chain function of mitochondria. Mito-
chondrial oxygen consumption rate of 143B cells stably expressing
Sirt3 shRNA was measured after incubation with 10 mM succinate as
the substrate and 1 mM ADP to activate the respiratory function. The
results revealed a signiﬁcant decrease in the oxygen consumption rateSirt3 
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222 Y.-T. Wu et al. / Biochimica et Biophysica Acta 1832 (2013) 216–227after ADP stimulation in the Sirt3 knockdown cells (Fig. 4A and B). We
also found that knockdown of Sirt3 caused retardation of cell growth
compared with the control cells (Fig. 4C).
To better understand the effect of acetylation of FoF1ATPase on the
bioenergetic function ofmitochondria,we grew control andSirt3 knock-
down cells in amedium inwhich glucosewas replaced by galactose.We
observed that the protein level of Sirt3was increased in the control 143B
cells grown in the galactose medium after 24 h as compared with the
levels in cells grown in the glucose-containing medium (Fig. 4D). As
shown in Fig. 4E, knockdown of Sirt3 increased cell death when the
cells had been cultured in galactose medium for 48 h, suggesting that
a loss of Sirt3 rendered the cells more susceptible to galactose-induced
cell death.C
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subunit of FoF1ATPase in human cells harboring 4977 bp-deleted mtDNA
To evaluate the role of Sirt3 in mitochondrial diseases, we deter-
mined the protein expression levels of Sirt3 in the skin ﬁbroblasts of
CPEO patients harboring 4977 bp-deleted mtDNA and those of age-
matched normal subjects, respectively. The results showed that the
average protein expression level of Sirt3 in the skin ﬁbroblasts of CPEO
patients was signiﬁcantly lower than that of normal skin ﬁbroblasts
(Fig. 5A). However, there was no difference in the average protein levels
of Sirt5, another mitochondrial sirtuin, between the two groups of skin
ﬁbroblasts. We then used the cybrids harboring the 4977 bp deletion
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shown in Fig. 5B, cybrids harboring ≅85% of mtDNA with 4977 bp dele-
tion had a signiﬁcantly lower protein expression level of Sirt3 as com-
pared with the wild-type cybrids. Moreover, the acetylation level of
FoF1ATPase was increased and a 1.5 fold increase in the acetylation of
OSCP was found in cybrids harboring 4977 bp deletion of mtDNA
compared to those of wild type cybrids (Fig. 5C). Furthermore, the
mutant cybrids with a decreased Sirt3 expression displayed a de-
cline in FoF1ATPase activity and a lower intracellular ATP content
(Fig. 5D and E). These results suggest that mtDNA 4977 bp deletionC
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the acetylation of FoF1ATPase.3.6. Oxidative stress suppresses Sirt3 expression and FoF1ATPase activity
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Fig. 6. Oxidative stress down-regulates Sirt3-mediated deacetylation and activity of FoF1ATPase. (A) Increase of intracellular ROS in cybrids with 4977 bp deletion of mtDNA. The
ROS level was represented by the intracellular superoxide anions levels, which were determined by the intensity of ethidium ﬂuorescence. Wild-type (0%) and cybrids with
4977 bp deletion of mtDNA (85% CD) were stained with hyroethidine (HE) and the ﬂuorescence intensity of 10,000 cells was analyzed using ﬂow cytometry. Data are presented
as mean±SD of the results from three independent experiments, *pb0.05. (B) Antioxidant treatment rescued the decline of Sirt3 in cells harboring 4977 bp deletion of mtDNA.
Cybrids were pretreated with 0.5 mM NAC for 72 h, and the protein levels of Sirt3 were analyzed by Western blot. (C) Menadione reduced the protein level of Sirt3 in a
dose-dependent manner. Aliquots of 143B cells were treated with 1, 2, 5, and 10 μMmenadione and DMSO control (Ctrl), respectively, for 24 h. Cell lysates were used for Western
blotting and probed with antibodies against Sirt3 and Sirt5, respectively. α-Tubulin was used as a loading control (upper panel). The relative protein level of Sirt3 over α-tubulin
was quantiﬁed (under panel). Quantiﬁed data are presented as the mean±SD of the results from three independent experiments. *pb0.05 and **pb0.01. (D) Menadione increased
the acetylation level of FoF1ATPase. Equal amounts of mitochondrial proteins from untreated and menadione-treated cells were immunoprecipitated, respectively, with an antibody
against acetyllysine, immunoprecipitates were immunoblotted with antibodies against α and OSCP subunits of FoF1ATPase to assess the degree of FoF1ATPase acetylation. (E) Re-
covery of menadione-diminished Sirt3 by NAC pretreatment. 143B cells were treated with DMSO or 10 μMmenadione, in the presence or absence of 0.5 mMNAC pretreatment, and
protein levels were analyzed by Western blot with an indicated antibody (upper panel). The relative protein level of Sirt3 over α-tubulin was quantiﬁed (lower panel). Quantiﬁed
data are presented as the mean±SD of the results from three independent experiments, and comparison among groups was conducted by ANOVA (*pb0.05). (F) Effect of an an-
tioxidant on the ATP hydrolysis activity of FoF1ATPase with menadione treatment. Solubilized SMP obtained from 143B cells treated with DMSO or menadione, in the presence or
absence of NAC pretreatment, was used to determine the ATP hydrolysis activity of FoF1ATPase. Values are expressed as the mean±SD of the results from three independent ex-
periments and groups were compared using ANOVA (*pb0.05).
224 Y.-T. Wu et al. / Biochimica et Biophysica Acta 1832 (2013) 216–227
225Y.-T. Wu et al. / Biochimica et Biophysica Acta 1832 (2013) 216–227with NAC to scavenge the ROS and found that the expression of Sirt3 was
recovered (Fig. 6B).
In order to explore the role of oxidative stress in the regulation of
Sirt3-mediated deacetylation, we usedmenadione, a free radical inducer
that forms superoxide anions during semiquinone reduction via redox
cycling, to induce ROS overproduction. After treatment for 24 h with 1,
2, 5 and 10 μMmenadione and DMSO, respectively, the protein expres-
sion levels of Sirt3 in 143B cells were determined by Western blotting.
As shown in Fig. 6C, the protein level of Sirt3 in cells treated with 5 μM
menadione was decreased to 60% of that of the control. Moreover, men-
adione was found to reduce Sirt3 expression in a dose-dependent man-
ner. The time course experiment revealed that menadione effectively
reduced the expression of Sirt3 at 8 h treatment (Supplementary Fig. 4).
By contrast, menadione had no effect on other sirtuins. We then
examined whether menadione could increase the acetylation level
of the subunits of FoF1ATPase. As shown in Fig. 6D, the acetylation
levels of α and OSCP subunits were increased after menadione treat-
ment of the cells as compared with the control.
To conﬁrm that the suppression of Sirt3 by menadione was due to
the overproduction of ROS, we pretreated 143B cells with an antioxi-
dant, N-acetyl cysteine (NAC), to remove the ROS elicited by menadi-
one. The results showed that the decrease in the expression of Sirt3
caused by menadione exposure was recovered by pretreatment of the
cells with NAC (Fig. 6E).Moreover, we observed thatmenadione caused
a decline of the FoF1ATPase activity, which was restored by NAC treat-
ment (Fig. 6F). These observations demonstrated that oxidative stress
is involved inmenadione-induced down-regulation of Sirt3. Altogether,
these results suggest that oxidative stress plays an important role in the
modulation of the deacetylation of mitochondrial proteins through
reduction of the expression of Sirt3 and subsequently results in the
functional impairment of FoF1ATPase in human cells.
4. Discussion
In the present study, we showed for the ﬁrst time that protein lysine
acetylation is involved in the regulation of FoF1ATPase activity in human
cells. We identiﬁed Sirt3 as a crucial regulator of the acetylation status
and activity of FoF1ATPase. Importantly, we found a decrease in the
expression and function of Sirt3 in human cells harboring a pathogenic
mtDNA mutation. Moreover, we proved that excessive production of
ROS could impair the function of Sirt3 in human cells.
We further demonstrated that OSCP has a physical association with
endogenous Sirt3, which can directly modulate the acetylation status of
OSCP. The OSCP subunit is a major constituent of the peripheral stalk,
and acts as a link between Fo and F1 domains [38,39]. It holds the αβ
catalytic core of the F1 domain to stay stationary against the torque of
the rotating central stalk of the enzyme. It was demonstrated that if
OSCP lost the binding with Fo or F1 domain, the structural integrity of
FoF1ATPase and its energy coupling function were impaired [40,41]. At
the mechanistic level, lysine acetylation not only neutralizes a positive
charge but also increases the hydrophobicity and size of the side chain
of lysine. Therefore, abnormalities in acetylation that occur in the
OSCP may result in a conformational change of OSCP itself or a space
impediment in the formation of a supercomplex with other subunits
of FoF1ATPase, which in turn affects its function of propagating
energy-linked conformational changes. It is rationalized that the physi-
cal association between OSCP and Sirt3 might prevent acetyl group-
elicited impact on the FoF1ATPase complex. In addition, we observed
an increase of acetylation in the α subunit of FoF1ATPase after knock-
down of Sirt3 (Fig. 1E). A speciﬁc binding between the N-terminal
regions of the OSCP andα subunit was demonstrated in the FoF1ATPase
frommany organisms [38,42,43]. In a recent study, the detailed structure
of N-terminal domain of bovine OSCP and its binding interface with α
subunit was elucidated by NMR [38]. Therefore, it is possible that a stable
binding with OSCP might lead to simultaneous deacetylation of the α
subunit by Sirt3. Our ﬁndings support the hypothesis that OSCP plays acrucial role in Sirt3-mediated deacetylation and energy coupling of
the FoF1ATPase in human cells.
Consistent with the previous reports that a decrease of Sirt3
compromised aerobic respiration [16,44], our ﬁndings substantiated
that depletion of Sirt3 resulted in the impairment of the respiratory
function of mitochondria. It has been reported that Sirt3 could regulate
the acetylation of NDUFA9 protein of mitochondrial Complex I and
affect NADH-dependent respiration in mice [45]. However, we did not
detect an increase in the acetylation level of NDUFA9 in Sirt3 knock-
down 143B cells as compared with control cells (Supplementary Fig. 5).
After excluding the possible effects of Complex I by using succinate as
the respiration substrate, we observed a remarkable reduction in the re-
spiratory function in Sirt3-deﬁcient cells. Recently, a loss of FoF1ATPase
activity was found to accompany a decrease in the rate of mitochondrial
oxygen consumption and led to structural instability of the neighboring
Complex III by impairment of the supercomplex formation [46]. It is
possible that Sirt3 deﬁciency-induced FoF1ATPase dysfunction might
indirectly compromisemitochondrial respiratory function capacity by af-
fecting the formation of mitochondrial supercomplexes and their elec-
tron transfer function.
Oxidative stress elicited by respiratory chain defects plays an impor-
tant role in the pathogenesis and progression of manymitochondrial dis-
orders and age-related diseases. We have reported that pathogenic
mtDNA mutation-induced oxidative stress is involved in the alteration
of the expression of several clusters of genes [34,47]. In the present
study, we demonstrated that oxidative stress is involved in the regulation
of Sirt3-mediated deacetylation. Our observations revealed that ROS
overproduction led to a reduction in cellular expression of Sirt3 and
subsequently resulted in the functional impairment of FoF1ATPase
(Fig. 6). Importantly, we showed for the ﬁrst time that Sirt3 deﬁciency
is associated with the bioenergetic dysfunction of a mitochondrial
disease, CPEO syndrome (Fig. 5). CPEO syndrome is one of themitochon-
drial encephalomyopathies that is often associated with large-scale dele-
tions of mtDNA, including the most common 4977 bp deletion [48]. One
of our previous studies reported that the production of ROS and oxidative
DNA damage in ﬁbroblasts from CPEO patients were higher than those of
normal subjects [35]. In this study, we also found that Sirt3 is signiﬁcantly
decreased in human cells harboring mtDNA with the 4977 bp deletion
and that contributes to enhanced acetylation of the OSCP subunit of FoF1-
ATPase (Fig. 5), which suggests that mitochondrial dysfunction leads to
an increase in the FoF1ATPase acetylation through the suppression of
Sirt3 and this might be associated with mtDNA mutation-elicited oxida-
tive stress.With regard to the impact of oxidative stress on Sirt3, the pro-
tein level of mitochondrial Sirt3 was observed to decline with age in the
skeletal muscle of the mouse [15,49], and deﬁciency in Sirt3 has been
reported to be associated with the occurrence of age-related cardiac hy-
pertrophy [50,51]. Besides, a similar decline of Sirt3 was also found in
type 2 diabetic mice [21]. These diseases are all related to the accumula-
tion of intracellular ROS. Moreover, abundant evidence showed that
Sirt3 was decreased inmice fed on high-fat diet or chronic ethanol inges-
tion [21,22], which are known to accompany the increase in the produc-
tion of ROS. These ﬁndings support the notion that overproduction of ROS
in pathological states could regulate mitochondrial protein acetylation
through suppression of Sirt3 via oxidative stress-mediated pathways
and consequently impair mitochondrial function. Intriguingly, it was
reported that a diabetic state results in a signiﬁcant decrease in the activ-
ity of FoF1ATPase and the capacity of oxidative metabolism in rat kidney
mitochondria [31]. A decrease in the FoF1ATPase activity and impaired
oxidative metabolism capacity were also observed in old mice [49].
Thus, whether impaired FoF1ATPase activity in aging and the above-
mentioned diseases is related to the impact of Sirt3 deﬁciency on the
acetylation of FoF1ATPase warrants further investigation.
In summary, our results have provided direct evidence of the impor-
tance of reversible acetylation in mitochondrial bioenergetic function
and its potential regulation by oxidative stress in mitochondrial diseases
such as CPEO syndrome. The results of this study also help us to gain a
226 Y.-T. Wu et al. / Biochimica et Biophysica Acta 1832 (2013) 216–227deeper insight into the importance of mitochondrial Sirt3 and facilitate
the development of novel strategies to manage the patients suffering
from mitochondrial diseases caused by mtDNA mutations as well as
other mitochondrial disorders. Drugs that can manipulate the expres-
sion and activity of Sirt3 may provide potential treatment for these
human diseases in the future.
5. List of abbreviations
CPEO chronic progressive external ophthalmoplegia
NAC N-acetylcysteine
NAM nicotinamide
OSCP oligomycin sensitivity conferring protein
RCR respiratory control ratio
ROS reactive oxygen species
shLuci shRNA for the luciferase gene
shSirt3 shRNA for the Sirt3 gene
Sirt3 sirtuin (silentmating type information regulator 2 homolog) 3
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